BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 2449461)

  • 1. Thymus in myasthenia gravis. Isolation of T-lymphocyte lines specific for the nicotinic acetylcholine receptor from thymuses of myasthenic patients.
    Melms A; Schalke BC; Kirchner T; Müller-Hermelink HK; Albert E; Wekerle H
    J Clin Invest; 1988 Mar; 81(3):902-8. PubMed ID: 2449461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-helper epitopes on human nicotinic acetylcholine receptor in myasthenia gravis.
    Moiola L; Protti MP; Manfredi AA; Yuen MH; Howard JF; Conti-Tronconi BM
    Ann N Y Acad Sci; 1993 Jun; 681():198-218. PubMed ID: 7689306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotinic acetylcholine receptor mRNAs in myasthenic thymuses: association with intrathymic pathogenesis of myasthenia gravis.
    Hara H; Hayashi K; Ohta K; Itoh N; Ohta M
    Biochem Biophys Res Commun; 1993 Aug; 194(3):1269-75. PubMed ID: 8352784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of myasthenia gravis. Acetylcholine receptor-related antigenic determinants in tumor-free thymuses and thymic epithelial tumors.
    Kirchner T; Tzartos S; Hoppe F; Schalke B; Wekerle H; Müller-Hermelink HK
    Am J Pathol; 1988 Feb; 130(2):268-80. PubMed ID: 2449082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amphipathic segment of the nicotinic receptor alpha subunit contains epitopes recognized by T lymphocytes in myasthenia gravis.
    Hohlfeld R; Toyka KV; Miner LL; Walgrave SL; Conti-Tronconi BM
    J Clin Invest; 1988 Mar; 81(3):657-60. PubMed ID: 2449458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary cultures of human myasthenia gravis thymus and normal thymus. Studies of cell morphology, cell proliferative pattern and localization of alpha-bungarotoxin binding sites on cultured thymic cells.
    Matsumoto Y; Furuya A; Kobayashi T; Tsukagoshi H
    J Neurol Sci; 1986 Sep; 75(2):121-33. PubMed ID: 3760907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the thymus in myasthenia gravis.
    Hohlfeld R; Wekerle H
    Adv Neuroimmunol; 1994; 4(4):373-86. PubMed ID: 7536601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the alpha 7 subunit of the nicotinic acetylcholine receptor in normal and myasthenic human thymuses.
    Navaneetham D; Penn A; Howard J; Conti-Fine BM
    Cell Mol Biol (Noisy-le-grand); 1997 May; 43(3):433-42. PubMed ID: 9193799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunopathological study related to myoglobin in myasthenic and non-myasthenic thymuses.
    Koeda T
    Acta Pathol Jpn; 1986 Feb; 36(2):209-23. PubMed ID: 3518335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cytokines on acetylcholine receptor expression: implications for myasthenia gravis.
    Poëa-Guyon S; Christadoss P; Le Panse R; Guyon T; De Baets M; Wakkach A; Bidault J; Tzartos S; Berrih-Aknin S
    J Immunol; 2005 May; 174(10):5941-9. PubMed ID: 15879086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myasthenia gravis.
    Marx A; Schultz A; Wilisch A; Nenninger R; Müller-Hermelink HK
    Verh Dtsch Ges Pathol; 1996; 80():116-26. PubMed ID: 9020569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro synthesis of IgG and antibodies to AChR by peripheral and thymic lymphocytes.
    Lisak RP; Levinson AI; Zweiman B; Kornstein MJ
    Ann N Y Acad Sci; 1987; 505():39-49. PubMed ID: 3500667
    [No Abstract]   [Full Text] [Related]  

  • 13. [Thymic abnormalities in patients with myasthenia gravis].
    Utsugisawa K; Nagane Y
    Brain Nerve; 2011 Jul; 63(7):685-94. PubMed ID: 21747138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetylcholine receptors in human thymic myoid cells in situ: an immunohistological study.
    Schluep M; Willcox N; Vincent A; Dhoot GK; Newsom-Davis J
    Ann Neurol; 1987 Aug; 22(2):212-22. PubMed ID: 3662452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific activation of lymphocytes against acetylcholine receptor in the thymus in myasthenia gravis.
    Fujii Y; Hashimoto J; Monden Y; Ito T; Nakahara K; Kawashima Y
    J Immunol; 1986 Feb; 136(3):887-91. PubMed ID: 2416838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-T lymphocyte interactions in experimental autoimmune myasthenia gravis: antigen presentation by rat/mouse hybridoma lines secreting monoclonal antibodies against the nicotinic acetylcholine receptor.
    Zhang YP; Tzartos SJ; Wekerle H
    Eur J Immunol; 1988 Feb; 18(2):211-8. PubMed ID: 2450756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistological studies of the thymus in myasthenia gravis. Correlation with clinical state and thymocyte culture responses.
    Thomas JA; Willcox HN; Newsom-Davis J
    J Neuroimmunol; 1982 Dec; 3(4):319-35. PubMed ID: 6757263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reflections on the "intrathymic pathogenesis" of myasthenia gravis.
    Hohlfeld R; Wekerle H
    J Neuroimmunol; 2008 Sep; 201-202():21-7. PubMed ID: 18644632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myoid cells and neuroendocrine markers in myasthenic thymuses.
    Zółtowska A; Pawełczyk T; Stopa M; Skokowski J; Stepiński J; Roszkiewicz A; Nyka W
    Arch Immunol Ther Exp (Warsz); 1998; 46(4):253-7. PubMed ID: 9779292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of Toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein-Barr virus infection.
    Cavalcante P; Galbardi B; Franzi S; Marcuzzo S; Barzago C; Bonanno S; Camera G; Maggi L; Kapetis D; Andreetta F; Biasiucci A; Motta T; Giardina C; Antozzi C; Baggi F; Mantegazza R; Bernasconi P
    Immunobiology; 2016 Apr; 221(4):516-27. PubMed ID: 26723518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.